Anna Maria Buehler

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 8

Top Topics

Decision Making

Pluripotent Stem Cells

Tyrosine Kinase

Metastatic Breast Cancer

Top Venues

Revista de saude publica

JCO global oncology

Therapeutic advances in medical oncology

Revista da Associacao Medica Brasileira (1992)

This page only lists publications with an associated author ORCID identifier.

Publications

Daniele Assad Suzuki, Alessandra Menezes Morelle, Mayana Lopes de Brito, Flavia Rocha Paes, André Mattar, Jorge H Santos Leal, Sérgio Daniel Simon, Ellias Magalhães Abreu Lima, Gustavo Werutsky, Gustavo H Munhoz Piotto, Jose Bines, Lucas Petri Damiani, Ariane Vieira Scarlatelli Macedo, Lígia Campos, Anna Maria Buehler
Real-World Evidence of Ribociclib Plus Aromatase Inhibitors as First-Line Treatment in Advanced Breast Cancer: The BrasiLEEira Study. JCO global oncology 10 (2024)
Daniele Assad Suzuki, Alessandra Menezes Morelle, Mayana Lopes de Brito, Flavia Rocha Paes, André Mattar, Jorge H Santos Leal, Sérgio Daniel Simon, Ellias Magalhães Abreu Lima, Gustavo Werutsky, Gustavo H Munhoz Piotto, Jose Bines, Lucas Petri Damiani, Ariane Vieira Scarlatelli Macedo, Lígia Campos, Anna Maria Buehler
Real-World Evidence of Ribociclib Plus Aromatase Inhibitors as First-Line Treatment in Advanced Breast Cancer: The BrasiLEEira Study. JCO global oncology 10 (2024)
Daniela Dornelles Rosa, Carlos Alberto da Silva Magliano, Sergio D Simon, Gilberto Amorim, Tomás Reinert, Luciana Landeiro, Débora de Melo Gagliato, Pedro Exman, Daniel Argolo, Gisah Guilgen, Max Mano, Laura Testa, Pedro Liedke, Romualdo Barroso, Mariana Sasse, Anna Maria Buehler
Cost-effectiveness of ribociclib for premenopausal or perimenopausal women with HR+/HER2- advanced breast cancer: a Brazilian public health care system perspective. Therapeutic advances in medical oncology 14 (2022)
Anna Maria Buehler, Pierre-Alexandre Dionne, David Chandiwana, Purnima Pathak, Ebuwa Igho-Osagie
Effect of ribociclib on productivity losses due to breast cancer in young women in Brazil. Revista de saude publica 56 (2022)
Anna Maria Buehler, Pierre-Alexandre Dionne, David Chandiwana, Purnima Pathak, Ebuwa Igho-Osagie
Effect of ribociclib on productivity losses due to breast cancer in young women in Brazil. Revista de saude publica 56 (2022)
Anna Maria Buehler, Pierre-Alexandre Dionne, David Chandiwana, Purnima Pathak, Ebuwa Igho-Osagie
Effect of ribociclib on productivity losses due to breast cancer in young women in Brazil. Revista de saude publica 56 (2022)
Anna Maria Buehler, Gabriela Castilho, Pierre-Alexandre Dionne, Stephen Stefani
Cost-effectiveness of ribociclib plus letrozole versus palbociclib plus letrozole or letrozole as monotherapy in first-line treatment of postmenopausal women with HR+/HER2- locally advanced or metastatic breast cancer: a Brazilian private payer perspective. Therapeutic advances in medical oncology 13 (2021)
Anna Maria Buehler, Bruna de Oliveira Ascef, Haliton Alves de Oliveira Júnior, Cleusa Pinheiro Ferri, Jefferson Gomes Fernandes
Rational use of diagnostic tests for clinical decision making. Revista da Associacao Medica Brasileira (1992) 65 (3) (2019)